What are the best treatments for Carcinoid Syndrome?

TL;DR: Treatment for Carcinoid Syndrome primarily focuses on controlling hormonal hypersecretion and managing symptoms through the use of somatostatin analogs, such as octreotide or lanreotide. Because Carcinoid Syndrome is complex and systemic, care is most effective when managed by a multidisciplinary team of specialists tailored to the individual’s specific tumor burden and hormonal profile.

What are the first-line medical treatments for Carcinoid Syndrome?

The cornerstone of managing Carcinoid Syndrome is the suppression of excess hormone production. First-line therapy typically involves somatostatin analogs (SSAs), which help reduce flushing and diarrhea by inhibiting the release of serotonin and other vasoactive substances. Common medications include octreotide (Sandostatin) and lanreotide (Somatuline). For patients who remain symptomatic despite standard SSA therapy, newer options like telotristat ethyl (Xermelo) may be prescribed to specifically inhibit tryptophan hydroxylase, the enzyme responsible for serotonin production in the tumor.

What non-pharmacological and surgical options are available?

When medication alone cannot control the symptoms of Carcinoid Syndrome, surgical or interventional procedures are often considered. These aim to reduce the overall "tumor burden," particularly in the liver, which is a common site for metastases that trigger systemic symptoms. Key interventions include:

• Surgical Debulking: Removing as much of the primary tumor and liver metastases as safely possible.


• Hepatic Artery Embolization: Cutting off the blood supply to liver tumors to induce necrosis.


• Radiofrequency Ablation: Using heat to destroy localized tumor tissue.


• Peptide Receptor Radionuclide Therapy (PRRT): A targeted internal radiation therapy (e.g., Lutetium Lu 177 dotatate) for patients with somatostatin receptor-positive tumors.

How should a care team be structured for Carcinoid Syndrome?

Effective management of Carcinoid Syndrome requires a multidisciplinary approach due to the systemic nature of the condition. Your care team should ideally include an endocrinologist, a medical oncologist, a gastroenterologist, and a surgeon specializing in neuroendocrine tumors (NETs). At DiseaseMaps.org, 49 people with Carcinoid Syndrome have shared their experiences, highlighting the value of coordinating care across these specialties to ensure that both the hormonal symptoms and the underlying cancer are addressed comprehensively.

How does treatment effectiveness vary between patients?

Treatment success in Carcinoid Syndrome is highly individualized, depending on the tumor's grade, location, and the specific hormones being secreted. While some patients achieve long-term stability with somatostatin analogs, others may require a more aggressive sequence of therapies. Regular monitoring of 5-HIAA levels and imaging scans is essential to determine how well the chosen treatment for Carcinoid Syndrome is working for your specific case.

Next steps

• Consult with a neuroendocrine tumor (NET) specialist at a high-volume academic medical center.


• Maintain a detailed symptom diary to help your physician optimize your dosage of somatostatin analogs.


• Join the Carcinoid Syndrome community at DiseaseMaps.org to connect with others sharing similar treatment journeys.


• Discuss current clinical trials for novel systemic therapies with your oncologist.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult your healthcare team for personalized treatment decisions.

References

• NIH Genetic and Rare Diseases (GARD) Information Center - Carcinoid Syndrome


• Orphanet: Rare Disease Database (ORPHA:135)


• North American Neuroendocrine Tumor Society (NANETS) Guidelines


• PubMed: Current Management Strategies for Carcinoid Syndrome